Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
P1 was found with an approximate size of 21 kDa and a PDI of 1.10
Ahead, the best apps for GLP-1 users, based on how people are actually using them
Metabolic Outcomes Beyond Weight Loss The clinical trials measured several metabolic parameters beyond body weight: Glycemic control (Type 2 diabetes trial Rosenstock et al., 2023) A separate Phase 2 trial in participants with type 2 diabetes (published in The Lancet ) demonstrated significant improvements in glucose metabolism
To summarise the scenarios, the Base Case (most likely) sees Pfizer muddling through the next 5 years with modest growth and income stability - a satisfactory outcome that would likely make the stock a market performer or slight outperformer (especially thanks to the dividend)
US$ 28.26
US$ 27.26
US$ 24.94
US$ 22.32
US$ 20.58
US$ 26.02
